Jim Simons Clearside Biomedical, Inc. Transaction History
Renaissance Technologies LLC
- $70.6 Billion
- Q2 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 496,589 shares of CLSD stock, worth $213,533. This represents 0.0% of its overall portfolio holdings.
Number of Shares
496,589
Previous 554,512
10.45%
Holding current value
$213,533
Previous $510,000
22.16%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding CLSD
# of Institutions
47Shares Held
11.8MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA3.36MShares$1.45 Million0.0% of portfolio
-
Act Capital Management, LLC Wayne, PA2.2MShares$944,9163.43% of portfolio
-
Carmignac Gestion Paris, I01.51MShares$648,5870.02% of portfolio
-
Black Rock Inc. New York, NY798KShares$343,1980.0% of portfolio
-
Geode Capital Management, LLC Boston, MA790KShares$339,8600.0% of portfolio
About Clearside Biomedical, Inc.
- Ticker CLSD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,190,700
- Market Cap $25.9M
- Description
- Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...